ArticleCancer research2011

Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies.

Harjeet Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.